MyFinsight
Home
Blog
About
Galera Therapeutics, Inc. (GRTX)
Galera Therapeutics, Inc. (GRTX)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Change in Cash
-$875K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Accounts payable
Prepaid expenses and other curre...
Share-based compensation expense
Accrued expense
Negative Cash Flow Breakdown
Net loss
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Net loss
-1,606
153,104
-1,388
-2,667
Acquired in-process research and development
-
0
-
-
Depreciation and amortization
-
0
0
0
Gain on sale of dismutase mimetics assets
-
3,500
-
-
Share-based compensation expense
78
92
91
227
Gain on extinguishment of debt
-
151,049
-
-
Write-off of acquired intangible asset
-
0
0
-
Loss on disposal of property and equipment
-
0
0
-
Write-off of goodwill
-
0
0
-
Deferred tax benefit
-
0
0
-
Change in fair value of warrants
0
0
0
-294
Prepaid expenses and other current assets
-157
292
-289
-360
Other liabilities
-
0
0
0
Other assets
0
0
0
1
Accounts payable
434
-169
232
-1,073
Accrued expense
62
216
19
-246
Cash used in operating activities
-875
-1,598
-757
-3,694
Cash paid for acquisition of nova
-
0
-
-
Proceeds from sale of property and equipment
-
0
0
-
Proceeds from sale of dismutase mimetics asset
-
3,500
-
-
Cash provided by investing activities
-
3,500
0
-
Proceeds from the sale of common stock in private placement
-
-
0
635
Proceeds from the sale of common stock and common stock warrants in private placement, net of issuance costs
0
635
-
-
Cash provided by financing activities
0
0
0
635
Net decrease in cash and cash equivalents
-875
1,902
-757
-3,059
Cash and cash equivalents at beginning of period
6,375
4,473
8,289
-
Cash and cash equivalents at end of period
5,500
6,375
4,473
-
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in cash
and cash...
-$875K
Accounts payable
$434K
Prepaid expenses and
other current assets
-$157K
Share-based compensation
expense
$78K
Accrued expense
$62K
Cash used in
operating activities
-$875K
Canceled cashflow
$731K
Net loss
-$1,606K
Buy us a coffee